EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integration of Raman Spectroscopy and Metabolomics for Early Breast Cancer Detection and Classification

Xue Li, He Ren iD, Yuhan Deng, Yang Li iD, Fangjie Hu

Cancer Medicine · 2026

DOI: 10.1002/cam4.71861 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Xue Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, P.R. China. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, Metabolomics, Breast Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer, now the fourth leading cause of cancer‐related mortality worldwide, necessitates early detection for improved clinical outcomes. Conventional histopathology, though widely used, is invasive and subjective, limiting its utility in early‐stage diagnosis. Here, we integrated confocal Raman spectroscopy with metabolomics to analyze biochemical and morphological features of breast tissues, including normal, fibroadenoma, ductal carcinoma in situ (DCIS), and invasive ductal carcinoma (IDC). Using spectral analysis and spectral unmixing, we mapped key biochemical components—proteins, lipids, and nucleic acids—across distinct tissue types. Cancerous tissues displayed heightened signals for proteins and nucleic acids but reduced lipids and carotenoids, reflecting profound metabolic alterations. Validation through metabolomic profiling revealed upregulated glycolytic and lipid synthesis pathways in tumor regions. Raman imaging further enabled precise classification of breast cancer subtypes, such as mucinous carcinoma and phyllodes tumors. These findings underscore the potential of Raman spectroscopy as a non‐invasive diagnostic modality for early detection and classification of breast cancer. The integration of Raman imaging with machine learning presents a promising avenue for advancing precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spectrum Analysis, RamanMetabolomicsBreast NeoplasmsEarly Detection of CancerHumansFemaleBiomarkers, Tumor

Stichwörter der Autor:innen

Raman spectroscopybiochemical compositionbreast tumorsmetabolitespathological statestissue imaging

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, P.R. China.
  • Department of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, P.R. China.
  • Department of Gastroenterology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: He Ren, Yang Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, X., Ren, H., Deng, Y., Li, Y., & Hu, F. (2026). Integration of Raman Spectroscopy and Metabolomics for Early Breast Cancer Detection and Classification. Cancer Medicine. https://doi.org/10.1002/cam4.71861

Vancouver

Li X, Ren H, Deng Y, Li Y, Hu F. Integration of Raman Spectroscopy and Metabolomics for Early Breast Cancer Detection and Classification. Cancer Medicine. 2026. doi:10.1002/cam4.71861

BibTeX
@article{Li2026,
  author = {Li, Xue and Ren, He and Deng, Yuhan and Li, Yang and Hu, Fangjie},
  title = {Integration of Raman Spectroscopy and Metabolomics for Early Breast Cancer Detection and Classification},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71861}
}
Kostenlos starten →